Oxidation-Reduction Agent

All categories
Name
Oxidation-Reduction Agent
Accession Number
DBCAT003567
Description

Not Available

Drugs
DrugDrug Description
MethylthioniniumThe phenothiazine cation in methylene blue commonly used to treat methemoglobinemia.
Methylene blueAn oxidation-reduction agent used for the treatment of pediatric and adult patients with acquired methemoglobinemia.
OmaveloxoloneA semisynthetic triterpenoid used to treat Friedreich’s ataxia in adults and adolescents 16 years and older.
Drugs & Drug Targets
DrugTargetType
MethylthioniniumAcetylcholinesterasetarget
MethylthioniniumBacterial regulatory protein, TetR familytarget
Methylene blueGuanylate cyclase soluble subunit alpha-2target
Methylene blueNitric oxide synthase, braintarget
Methylene blueUDP-glucuronosyltransferase 1-4enzyme
Methylene blueUDP-glucuronosyltransferase 1-9enzyme
Methylene blueCytochrome P450 1A2enzyme
Methylene blueCytochrome P450 2B6enzyme
Methylene blueCytochrome P450 2C8enzyme
Methylene blueCytochrome P450 2C9enzyme
Methylene blueCytochrome P450 2C19enzyme
Methylene blueCytochrome P450 3A4enzyme
Methylene blueCytochrome P450 3A5enzyme
Methylene blueSerum albumincarrier
Methylene blueP-glycoprotein 1transporter
Methylene blueSolute carrier family 22 member 2transporter
Methylene blueMultidrug and toxin extrusion protein 2transporter
Methylene blueMultidrug and toxin extrusion protein 1transporter
Methylene blueFlavin reductase (NADPH)enzyme
Methylene blueCytochrome P450 2D6enzyme
OmaveloxoloneKelch-like ECH-associated protein 1target
OmaveloxoloneCytochrome P450 3A4enzyme
OmaveloxoloneCytochrome P450 2C8enzyme
OmaveloxoloneCytochrome P450 2J2enzyme
OmaveloxoloneSolute carrier family 22 member 6transporter